Page last updated: 2024-11-10

enpiroline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

enpiroline: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3033333
CHEMBL ID2110920
SCHEMBL ID2110557
MeSH IDM0081379

Synonyms (18)

Synonym
enpiroline
wr-180409
(r)-[(2r)-piperidin-2-yl]-[2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]pyridin-4-yl]methanol
4-pyridinemethanol, alpha-2-piperidinyl-2-(trifluoromethyl)-6-(4-(trifluoromethyl)phenyl)-, (r*,r*)-(+-)-
enpiroline [inn]
enpirolinum [latin]
8m7y72ep9k ,
4-pyridinemethanol, alpha-(2r)-2-piperidinyl-2-(trifluoromethyl)-6-(4-(trifluoromethyl)phenyl)-, (alphar)-rel-
enpirolina [spanish]
enpirolina
enpirolinum
unii-8m7y72ep9k
(+/-)-(r*,r*)-.alpha.-((2-(trifluoromethyl)-6-(.alpha.,.alpha.,.alpha.-trifluoro-p-tolyl)-4-pyridyl)-2-piperidinemethanol
4-pyridinemethanol, .alpha.-(2-piperidinyl)-2-(trifluoromethyl)-6-(4-(trifluoromethyl)phenyl)-, (r*,r*)-(+/-)-
SCHEMBL2110557
Q27270751
CHEMBL2110920
ocvrkdmrzfcuee-rhsmwyfysa-n
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1752678Antischistosomal activity against Schistosoma mansoni Liberian infected in NMRI mouse assessed as worm burden reduction at 200 mg/kg, po measured after 14 days relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's4 (30.77)18.2507
2000's0 (0.00)29.6817
2010's2 (15.38)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.24 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]